Alaffia Health
Category: AI in Healthcare
An AI-powered payment integrity platform that leverages agentic AI to automate the detection and correction of medical billing errors, fraud, waste, and abuse for healthcare payers. Alaffia Health was founded in 2020. The company is led by TJ Ademiluyi. Based in New York, USA. Team size: 50-100. Total funding raised: $72.4M. Latest round: Series B. Key investors include ["Transformation Capital","FirstMark Capital","General Catalyst","Anthemis Group","GingerBread Capital"].
- Founded
- 2020
- Headquarters
- New York, USA
- Team size
- 50-100
- Total funding
- $72.4M
Value proposition
Eliminates administrative waste and improper payments by replacing manual, labor-intensive claim reviews with autonomous AI agents that can process complex clinical documentation in real-time.
Products and solutions
["Autodor (Integrated claim review SaaS platform)","Autodor AI Agents™ (Custom-built autonomous AI coworkers for claims operations)","Ask Autodor (Generative AI co-pilot for claims teams)","Payment-Integrity-as-a-Service (Turnkey clinical review and recovery solution)","Automated Clinical Reasoning & Intelligent Routing Engine"]
Unique value
Utilizes 'Agentic AI'—autonomous systems capable of navigating complex clinical nuance and coding rules to make decisions, rather than just flagging anomalies for human review.
Target customer
Commercial health insurance plans, Third-Party Administrators (TPAs), self-insured employers, and government agencies (Medicaid and Medicare Advantage).
Industries served
["Healthcare","Health Insurance (Payers)","Insurtech","Medical Billing & Coding"]
Technology advantage
Combines proprietary LLMs trained on vast medical claim datasets with deep domain expertise from its founders (a sibling duo with backgrounds in medical billing operations and high-stakes financial analysis).
How they differentiate
Utilizes 'Agentic AI' to perform autonomous clinical reasoning and claim reviews, moving beyond legacy rules-based engines and manual human-in-the-loop audits used by incumbents.
Main competitors
["Cotiviti","Claris Health","Change Healthcare (Optum)"]
Key partnerships
["Strategic investment partners including Transformation Capital, FirstMark Capital, and General Catalyst","Recognized as a 'Major Contender' in Everest Group’s Payment Integrity Solutions PEAK Matrix","Member of the Association for Community Affiliated Plans (ACAP)"]
Notable customers
["Association for Community Affiliated Plans (ACAP) members","Commercial Health Plans","Third-Party Administrators (TPAs)"]
Major milestones
["Named a 'Major Contender' in Everest Group’s 2024 Payment Integrity Solutions PEAK Matrix","Launched 'Autodor AI Agents' for autonomous claims operations in 2024","Closed $55M Series B funding round in February 2025 to scale agentic AI capabilities"]
Growth metrics
Achieved 4x revenue growth in 2024; scaled team to 60+ employees with plans to reach 100+ by 2026.
Market positioning
AI-first challenger in the payment integrity and medical billing fraud detection space, targeting mid-to-large health plans and TPAs.
Geographic focus
North America (United States healthcare market)
Patents and IP
No specific public patents disclosed; holds registered trademarks for core AI products including Autodor AI Agents™.
About TJ Ademiluyi
TJ Ademiluyi is the Co-founder and CEO of Alaffia Health. Before launching the company in 2020, he spent five years at Goldman Sachs within the Investment Banking Division, progressing from Analyst to Associate. His experience in high-stakes financial analysis and capital markets provided the foundation for tackling the $570 billion waste problem in the US healthcare system. He was recognized in the Forbes 30 Under 30 Healthcare list in 2023.
Official website: https://www.alaffiahealth.com